The Veterinary Diagnostics Market can be analyzed according to product type, technology, animal type, testing type, disease type, end use, and region.

By product type, kits and reagents represented approximately 43% of market share in 2025. Instruments contributed approximately USD 2.78 billion in revenue, while software and services are forecast to be the fastest-growing product category, supported by increasing adoption of cloud-based laboratory information management systems.

By technology, immunodiagnostics accounted for approximately 42% of 2025 revenue. Molecular diagnostics are expected to expand at a CAGR of 10.4% through 2035 due to declining testing costs and the introduction of multiplex testing panels.

By animal type, companion animals represented approximately 58% of market sales in 2025. The segment benefits from increasing pet humanization and greater spending on preventive veterinary care. Livestock diagnostics are also expected to grow strongly as governments implement disease-surveillance programs.

By end user, veterinary hospitals and clinics represented approximately 51% of market revenue in 2025. Laboratories, point-of-care and in-house testing facilities, research institutes, and universities also contribute to overall demand.

Regionally, North America held the largest share in 2025, followed by Europe. Asia-Pacific is expected to register the fastest growth during the forecast period.

This diverse segmentation highlights opportunities for diagnostic equipment manufacturers, reagent suppliers, laboratory service providers, and veterinary technology companies.